-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalyn Pharma Q2 EPS $(0.65) Misses $(0.53) Estimate

Benzinga·08/12/2026 12:13:23
Listen to the news
Avalyn Pharma (NASDAQ:AVLN) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0.53) by 22.64 percent.